| Quantity: | |
|---|---|
This product containsinactivated filamentous mycoplasma goat subspecies C87-1 strain.（CVCC 87001）
After standing, the upper layer is a clear liquid with a small amount of sediment at the bottom, which forms a homogeneous suspension after shaking. Upon standing, a clear supernatant forms on the top with a small amount of sediment at the bottom; a homogeneous suspension is formed after thorough shaking.
For the prevention of caprine infectious pleuropneumonia in goats. Protective immunity is generated after complete vaccination, with the immunity period lasting for 12 months.
For subcutaneous or intramuscular injection. Administe 5.0 mLper adult goat; 3.0 mL per lamb under 6 months of age.
20 mL/bottles;50mL/bottle;100mL/bottle
Store at 2–8 °C. Shelf life: 18months from the date of manufacture.
For use only under veterinary supervision.
Classic C87-1 strain for precise prevention of caprine pleuropneumonia: Adopts exclusive standard C87-1 strain of Mycoplasma mycoides subsp. capri, which adapts to domestic prevalent strains with excellent immunogenicity and stable performance. It targets caprine infectious pleuropneumonia and solves typical problems such as cough, asthma, inflammation and mortality in goat flocks.
Mature inactivation technology ensures high safety and stability: Adopts thorough and advanced inactivation technology with no live virus risk and low irritation. The stable suspension formulation causes no obvious adverse reactions after standard vaccination, without affecting feeding, growth and fattening performance of goats.
Age-specific dosage adapts to goats at different stages: Scientific differentiated dosage design for adult goats and lambs matches the immune characteristics of different ages. Accurate dosage ensures sufficient and balanced immune protection for both adult goats and young lambs.
Dual flexible vaccination methods adapt to various breeding scenarios: Supports both subcutaneous and intramuscular injection with simple and efficient operation. It can be flexibly selected according to farm habits and scales, fully adapting to batch immunization for all types of goat farms.
Stable suspension formulation for efficient on-site operation: The vaccine produces only a small amount of precipitation after standing and forms a uniform suspension after shaking. It is easy to operate with accurate and uniform immune dosage, ensuring consistent flock antibody level.
Q: What type of vaccine is this? What diseases does it prevent?
A: This is an inactivated vaccine for caprine infectious pleuropneumonia, a non-prescription veterinary drug, specially used to prevent mycoplasma respiratory diseases in goats.
Q: What are the applicable goats, vaccination method and standard dosage?
A: Applicable to healthy goats via subcutaneous or intramuscular injection. The dosage is 3.0ml per lamb (under 6 months old) and 5.0ml per adult goat for targeted immune protection.
Q: How long is the immune protection period after standard vaccination?
A: The immune duration lasts up to 12 months after standard vaccination, providing full-year long-term protection and covering the whole growth, fattening and breeding cycle of goats.
Q: What are the key operation requirements before vaccine use?
A: Warm the vaccine to room temperature and shake fully before vaccination. Strictly disinfect injection sites and appliances with standardized aseptic operation, and only vaccinate healthy goat flocks.
Q: What are the core storage and transportation taboos?
A: Store and transport at 2～8℃ away from light. Freezing is strictly prohibited, as frozen vaccine will suffer formulation damage and complete failure.
Q: How to conduct harmless disposal of vaccine wastes?
A: All wastes such as residual vaccine, used vaccine bottles and inoculation appliances must be uniformly collected and harmlessly disposed of in accordance with veterinary epidemic prevention specifications to eliminate biosafety risks.
